Design, Synthesis and molecular docking study of hybrids of quinazolin-4(3H)-one as anticancer agents
Keywords:
Quinazolin-4(3H)-one, Thiazolidin-4-one, Anticancer activity, Molecular dockingAbstract
A series of 4-(2-(4-substituted phenyl)-4-oxoquinazolin-3(4H)-yl)-N-(2-(4-fluorophenyl)-4-oxo-5-(arylidene)thiazolidin-3-yl) benzamides (VIa-n) have been synthesized by condensation of N-(2-(4-fluorophenyl)-4-oxothiazolidin-3-yl)-4-(4-oxo-2-(4-substituted phenyl)quinazolin-3(4H)-yl)benzamides (Va-b) with various aryl/heteroaryl aldehydes using conventional methodology. All compounds were screened for their in vitro anticancer activity against the human breast cancer cell lines (MCF-7), human lung cancer cell lines (A549) using MTT assay method and doxorubicin is used as standard drug. Compound VId, VIk and VIn showed high potency against A549 cell lines with IC50 values 0.035±0.002 µM, 0.031±0.002 µM and 0.030±0.002 µM respectively compared to 0.023±0.002 µM showed by the standard. However, highest activity against MCF-7 cell lines was exhibited by Va, Vb, VIk and VIn with IC50 values between 0.040 - 0.050 µM. All the remaining compounds showed moderate anticancer activity against both the MCF-7 and A549 cell lines. To understand the interactions with active binding site of receptor, molecular docking study was also performed.
Downloads
References
Deep A, Narasimhan B, Ramasamy K, Mani V, Mishra RK, Abdul-Majeed AB. Synthesis, Antimicrobial, Anticancer Evaluation and QSAR Studies of Thiazolidin-4-Ones Clubbed with Quinazolinone. Curr Top Med Chem. 2013;13(16):2034-46. DOI: 10.2174/15680266113139990130
Appalanaidu K, Rajesh K, Dadmal TL, Bollu VS, Ravindra MK, Patra CR. Synthesis and biological evaluation of novel 2-imino-4-thiazolidinone derivatives as potent anti-cancer agents. Bioorg Med Chem Lett. 2016;26:5361-5368. DOI: http://dx.doi.org/10.1016/j.bmcl.2016.08.013
El-Azab AS, Al-Omar MA, Abdel-Aziz AM, Abdel-Aziz NI, El-Sayed MA, Aleisa AM, Sayed-Ahmed MM, Abdel-Hamide SG. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: Molecular docking study. Eur J Med Chem. 2010;45:4188-4198. DOI:10.1016/j.ejmech.2010.06.013
Palem JD, Alugubelli GR, Bantu R, Nagarapu L, Polepalli S, Jain SN, Bathini R, Manga V. Quinazolinones-Phenylquinoxaline hybrids with unsaturation/saturation linkers as novel anti-proliferative agents. Bioorg Med Chem Lett. 2016;26:3014-3018. DOI: http://dx.doi.org/10.1016/j.bmcl.2016.05.021
Godhani DR, Jogel AA, Dobariya PB, Sanghani AM. Synthesis, characterization and biological evaluation of 4-oxo-thiazolidine compounds. J Saudi Chem Soc. 2016;20:S523-S535. DOI: http://dx.doi.org/10.1016/j.jscs.2013.03.002
Barbosa VA, Baréa P, Mazia RS, Ueda-Nakamura T, Costa WF, Foglio MA, Goes-Ruiz ALT, Carvalho JE, Vendramini-Costa DB, Nakamura CV, Sarragiotto MH. Synthesis and evaluation of novel hybrids β-carboline-4-thiazolidinones as potential antitumor and antiviral agents. Eur J Med Chem. 2016;124:1093-1104. DOI: 10.1016/j.ejmech.2016.10.018
Samridhi T, Deepika S, Ashwani K, Neelam J, Sandeep J. A synthetic approach and molecular docking study of hybrids of quinazolin-4-ones and thiazolidin-4-ones as anticancer agents. Med Chem Res. 2017:26;8:1595-1604. DOI 10.1007/s00044-017-1857-2
Ahmed MF, Youns M. Synthesis and Biological Evaluation of a Novel Series of 6,8-Dibromo-4(3H)quinazolinone Derivatives as Anticancer Agents. Arch Pharm Chem Life Sci. 2013;(346):610-617. DOI 10.1002/ardp.201300158
Hei YY, Xin M, Zhang H, Xie XX, Mao S, Zhang SQ. Synthesis and antitumor activity evaluation of 4,6-disubstituted quinazoline derivatives as novel PI3K inhibitors. Bioorg Med Chem Lett. 2016;26:4408-4413. DOI: http://dx.doi.org/10.1016/j.bmcl.2016.08.015
Xin M, Duan W, Feng Y, Hei YY, Zhang H, Shen Y, Zhao HY, Mao S, Zhang SQ. Introduction of pyrrolidineoxy or piperidineamino group at the 4-position of quinazoline leading to novel quinazoline-based phosphoinositide 3-kinase delta (PI3Kδ) inhibitors. J Enzyme Inhib Med Chem. 2018;33(1):651-656. DOI: https://doi.org/10.1080/14756366.2018.1444608
Palkar MB, Singhai AS, Ronad MP, Vishwanathswamy AHM, Boreddy ST, Veerapur VP, Shaikh SM, Rane RA, Karpoormath R. Synthesis, pharmacological screening and in silico studies of new class of Diclofenac analogues as a promising anti-inflammatory agents. Bioorg Med Chem. 2014;22:2855-2866. DOI: http://dx.doi.org/10.1016/j.bmc.2014.03.043
Desai NC, Dodiya AM. Synthesis, characterization and antimicrobial screening of quinoline based quinazolinone-4-thiazolidinone heterocycles. Arab J Chem. 2014;7:906-913. DOI: http://dx.doi.org/10.1016/j.arabjc.2011.08.007
Desai NC, Vaghani HV, Shihora PN. A new hybrid approach and in vitro antimicrobial evaluation of novel 4(3H)-quinazolinones and thiazolidinone motifs. J Fluor Chem. 2013;153:39-47. DOI: http://dx.doi.org/10.1016/j.jfluchem.2013.05.022
Nanda AK, Ganguli S, Chakraborty R. Antibacterial Activity of Some 3-(Arylideneamino)-2-phenylquinazoline-4(3H)-ones: Synthesis and Preliminary QSAR Studies. Molecules. 2007;12:2413-2426. DOI: https://doi.org/10.3390/12102413
Liu Y and Nair MG. An Efficient and Economical MTT Assay for Determining the Antioxidant Activity of Plant Natural Product Extracts and Pure Compounds. J Nat Prod. 2010;73:1193-1195. DOI: 10.1021/np1000945
Van-Meerloo J, Kaspers GJ, Cloos J. Cell Sensitivity Assays: The MTT Assay. In: Cree IA, editor. Cancer Cell Culture. Methods in Molecular Biology (Methods and Protocols). New York: Humana Press; 2011. p. 237-245. DOI: 10.1007/978-1-61779-080-5_20
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 Sukanya Nara, Achaiah Garlapati
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The articles, which are published in this journal, are subject to the following terms in relation to the rights of patrimonial or exploitation:
- The authors will keep their copyright and guarantee to the journal the right of first publication of their work, which will be distributed with a Creative Commons BY-NC-SA 4.0 license that allows third parties to reuse the work whenever its author, quote the original source and do not make commercial use of it.
b. The authors may adopt other non-exclusive licensing agreements for the distribution of the published version of the work (e.g., deposit it in an institutional telematic file or publish it in a monographic volume) provided that the original source of its publication is indicated.
c. Authors are allowed and advised to disseminate their work through the Internet (e.g. in institutional repositories or on their website) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).
